UK markets open in 3 hours 23 minutes

Oncopeptides AB (publ) (0RN4.IL)

IOB - IOB Delayed price. Currency in SEK
Add to watchlist
3.0911+0.1811 (+6.22%)
At close: 04:35PM BST
Full screen
Previous close2.9525
Open0.0000
Bid3.1250 x N/A
Ask3.3750 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume3,710,560
Avg. volume15,135
Market cap317.014M
Beta (5Y monthly)-0.66
PE ratio (TTM)N/A
EPS (TTM)-3.3900
Earnings date30 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

    DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this e